Experienced in Axial Spondyloarthritis (AxSpA)

Dr. Ghaith Noaiseh

Rheumatology
Kansas University Physicians Inc
1000 E 101st Ter, Urology, 
Kansas City, MO 
Accepting New Patients
Offers Telehealth
Experienced in Axial Spondyloarthritis (AxSpA)
Kansas University Physicians Inc
1000 E 101st Ter, Urology, 
Kansas City, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ghaith Noaiseh is a Rheumatologist in Kansas City, Missouri. Dr. Noaiseh is rated as an Experienced provider by MediFind in the treatment of Axial Spondyloarthritis (AxSpA). His top areas of expertise are Sjogren Syndrome, Interstitial Keratitis, Undifferentiated Connective Tissue Disease (UCTD), and Rheumatoid Arthritis (RA). Dr. Noaiseh is currently accepting new patients.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in MO
Hospital Affiliations
University Of Kansas Hospital
Languages Spoken
English
Arabic
Hindi
Japanese
Mandarin
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

KANSAS UNIVERSITY PHYSICIANS INC
1000 E 101st Ter, Urology, Kansas City, MO 64131
Other Locations
KANSAS UNIVERSITY PHYSICIANS INC
4000 Cambridge St, Kansas City, KS 66160

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 18, 2022
Intervention Type: Drug
Study Drug: JBT-101
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Completed
Publish Date: November 21, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

9 Total Publications

Recommendations for Aligned Nomenclature of Peripheral Nervous System Disorders Across Rheumatology and Neurology.
Recommendations for Aligned Nomenclature of Peripheral Nervous System Disorders Across Rheumatology and Neurology.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 02, 2024
Similar Doctors
Distinguished in Axial Spondyloarthritis (AxSpA)
Dr. Michael W. Smith
Rheumatology
Distinguished in Axial Spondyloarthritis (AxSpA)
Dr. Michael W. Smith
Rheumatology

Kansas City Physician Partners Inc

4440 Broadway Blvd, 
Kansas City, MO 
 (7.1 miles away)
816-561-9200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Smith is a Rheumatologist in Kansas City, Missouri. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Axial Spondyloarthritis (AxSpA). His top areas of expertise are Rheumatoid Arthritis (RA), Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis. Dr. Smith is currently accepting new patients.

Advanced in Axial Spondyloarthritis (AxSpA)
Dr. Kalista T. Engelman
Rheumatology
Advanced in Axial Spondyloarthritis (AxSpA)
Dr. Kalista T. Engelman
Rheumatology

Kansas City Physician Partners Inc

8350 N Saint Clair Ave, Suite 100, 
Kansas City, MO 
 (21.2 miles away)
913-258-2116
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kalista Engelman is a Rheumatologist in Kansas City, Missouri. Dr. Engelman is rated as a Distinguished provider by MediFind in the treatment of Axial Spondyloarthritis (AxSpA). Her top areas of expertise are Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Ankylosing Spondylitis. Dr. Engelman is currently accepting new patients.

Advanced in Axial Spondyloarthritis (AxSpA)
Dr. Tina U. Shah
Rheumatology | Hospital Medicine
Advanced in Axial Spondyloarthritis (AxSpA)
Dr. Tina U. Shah
Rheumatology | Hospital Medicine

Kansas City Physician Partners Inc

8350 N Saint Clair Ave, Suite 100, 
Kansas City, MO 
 (21.2 miles away)
913-258-2116
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Tina Shah is a Rheumatologist and a Hospital Medicine provider in Kansas City, Missouri. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Axial Spondyloarthritis (AxSpA). Her top areas of expertise are Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Raynaud Phenomenon. Dr. Shah is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Noaiseh's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile